Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is a a life sciences service organization, provides drug discovery, development, contract manufacturing, and formulation research and development services.
Aragen Life Sciences Limited, is an unlisted public company incorporated on 07 December, 2000. It is classified as a public limited company and is located in , . It's authorized share capital is INR 250.00 cr and the total paid-up capital is INR 216.99 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Manmahesh Kantipudi | 05241166 | 7 years |
Director | Davinder Singh Brar
Shareholder
|
00068502 | 21 years |
Director | Robert Richard Ruffolo | 08404004 | 6 years |
Director | Keshav Gunupati Venkat Reddy | 06593325 | 5 years |
Director | Ajay Srivastava | 00049912 | 4 years |
Director | Rajat Sood | 07914803 | 4 years |
Director | Anita Ramachandran | 00118188 | 3 years |
Director | Amit Varma | 02241746 | 1 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Kotak Mahindra Bank Limited
No. of Loans: 3
Total Amount : 275.0 cr
CitiBank N.A.
No. of Loans: 5
Total Amount : 251.8 cr
Yes Bank Limited
No. of Loans: 1
Total Amount : 57.0 cr
The Federal Bank Limited
No. of Loans: 1
Total Amount : 50.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
INTOX PRIVATE LIMITED | Maharashtra | 2000 | ₹ 76.0 L |
Aragen Bioscience, Inc. | United States | - | - |
Aragen Lifesciences B.V | Netherlands | - | - |
ARAGEN FOUNDATION | Delhi | 2021 | ₹ 1.0 L |
ARAGEN BIOLOGICS PRIVATE LIMITED | Telangana | 2023 | ₹ 1.0 L |
Aragen Bioscience, Inc. | United States | - | - |
Aragen Lifesciences B.V | Netherlands | - | - |
Read more
The incorporation date of ARAGEN LIFE SCIENCES LIMITED is 07 December, 2000
The authorized share capital of ARAGEN LIFE SCIENCES LIMITED is INR ₹ 250.0 Cr.
The paid-up capital of ARAGEN LIFE SCIENCES LIMITED is INR ₹ 217.0 Cr.
The registered address of ARAGEN LIFE SCIENCES LIMITED is Plot 28A, IDA Nacharam, Hyderabad, Telangana, India, 500076 - 500076
The CIN number of ARAGEN LIFE SCIENCES LIMITED is U74999TG2000PLC035826.